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Abstract. The first step of assembly of the nicotinic 
acetylcholine receptor (AChR) of adult skeletal muscle 
is the specific association of the o~ subunit with either 
or ~ subunits to form a heterodimer with a ligand-bind- 
ing site. Previous experiments have suggested that het- 
erodimer formation in the ER arises from interaction 
between the luminal, NH2-terminal domains of the sub- 
units. When expressed in COS cells with the 8 subunit, 
however, the truncated NH2-terminal domain of the 
e~ subunit folded correctly but did not form a hetero- 
dimer. Association with the ~ subunit occurred only 
when the NH2-terminal domain was retained in the ER 
and was tethered to the membrane by its own M1 trans- 
membrane domain, by the transmembrane domain of 
another protein, or by a glycolipid link. In each case, 
the ligand-binding sites of the resulting heterodimers 
were indistinguishable from that formed when the full- 
length ot subunit was used. Attachment to the mem- 
brane may promote interaction by concentrating or ori- 
enting the subunit; alternatively, a membrane-bound 
factor may facilitate subunit association. 
T 
HE  nicotinic  acetylcholine  receptor  (AChR) 1  in 
Torpedo electrical organ and mammalian skeletal 
muscle is the most widely studied member of a large 
family of ligand-gated ion channels (Betz,  1990; Unwin, 
1993; Karlin and Akabas, 1995). The AChR is a heterooli- 
gomeric membrane protein formed by four different sub- 
units in the stoichiometry tx213~ (in adult mammalian skel- 
etal muscle) or c~2138~/(in fetal skeletal muscle and Torpedo 
electric organ) (Gu et al., 1990; Galzi et al., 1991; Karlin, 
1991, 1993). The subunits of AChR are highly homologous 
and are arranged pseudosymetrically to surround a central 
aqueous pore through which ions flow (Karlin et al., 1983; 
Unwin, 1993).  Each of the subunits is synthesized in the 
ER as a single polypeptide chain (Anderson and Blobel, 
1981) that assumes a characteristic topology: a long, NH2- 
terminal,  extracellular  domain, four  transmembrane  re- 
gions,  and  a  short,  COOH-terminal  extracellular  tail 
(Noda et al., 1982; Claudio, 1989; Chavez and Hall, 1991; 
Karlin, 1993). Like other oligomeric membrane proteins in 
the  cell  (Rose  and  Doms,  1988; Hurtley and  Helenius, 
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1989), the peptide chains of AChR undergo folding reac- 
tions shortly after synthesis (Merlie  and Sebbane,  1981; 
Merlie and Lindstrom, 1983). Properly folded subunits are 
assembled into a functional pentamer in the ER before be- 
ing transported to the Golgi apparatus and from there to 
the cell surface (Smith et al., 1987; Gu et al., 1989; Blount 
et al., 1990; Green and Claudio, 1993). 
Studies using heterologous expression systems with dif- 
ferent combinations of subunits have delineated a distinc- 
tive scheme for AChR assembly, in which the first step is 
the  formation of the  heterodimers  a8  and  o~  (or  cx~/) 
(Blount et al., 1990; Gu et al., 1991; Saedi et al., 1991). The 
interactions between subunits are highly specific, as het- 
erodimer formation between a and 13 subunits does not oc- 
cur even though they contact each other as neighbors in 
the fully assembled oligomer. The folded at subunit binds 
a-bungarotoxin (et-BuTx) in the absence of other subunits 
but only binds small, cholinergic ligands with high affinity 
after its association with 8 or ~ (~/) subunits (Blount and 
Merlie,  1988, 1989).  The ligand-binding sites of the two 
heterodimers have distinct pharmacological features that 
correspond to the two nonequivalent sites found in the in- 
tact AChR (Karlin, 1991; Sine and Claudio, 1991; Fu and 
Sine, 1994).  As the two et subunits in each receptor pen- 
tamer have identical primary polypeptide sequences, the 
nonequivalent binding of cholinergic ligands to identical 
subunits is thought to be caused by structural influences of 
different neighboring subunits (Blount and Merlie, 1989; 
Sine,  1993).  Indeed,  photoaffinity labeling  experiments 
have shown that 8 and "y subunits contribute domains for 
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and Cohen, 1990; Karlin and Akabas, 1995). The [3 subunit 
itself does not participate directly in the formation of a 
ligand-binding site, although it is essential for assembly of 
the final AChR pentamer (Blount et al., 1990; Gu et al., 
1991; Saedi et al., 1991). 
The association of subunits to form a  heteromultimer 
with correct stoichiometry and subunit position requires 
domains within the sequence of each subunit that confer 
identity on it and allow it to recognize its neighbors. By 
studying the assembly of chimeric subunits and the domi- 
nant  negative  effects of truncated  AChR  subunit  frag- 
ments, we and others have suggested that heterodimer for- 
mation occurs primarily through interactions between the 
extracellular NH2-terminal domains of the AChR subunits 
(Yu  and Hall,  1991,  1994;  Hall,  1992;  Verrall  and  Hall, 
1992;  Sumikawa and Nishizaki,  1994; Kreienkamp et al., 
1995). We show here that although the soluble NHz-termi- 
nal domain of the a  subunit folds correctly, it does not as- 
sociate with the ~ subunit unless it is attached to the mem- 
brane, either by its own M1  transmembrane domain, by 
the  transmembrane  domain of another protein, or by a 
glycolipid link. Our data establish that the NH2-terminal 
domain of the tx subunit is an independent functional en- 
tity that possesses all of the structural information needed 
for folding, specific subunit association, and formation of a 
ligand-binding site. Efficient subunit association, however, 
requires retention of the subunit domain in the ER and as- 
sociation with the membrane. 
Materials and Methods 
Expression Vectors and Antibodies 
Full-length cDNAs coding for the ct, 13, and ~ subunits of mouse muscle 
nicotinic AChR were kindly provided by Drs. J.P. Merlie (Washington 
University, St. Louis, MO) and N. Davidson (California Institute of Tech- 
nology, Pasadena, CA) (a, Isenberg et al., 1986; [3, Buonanno et al., 1986; 
8, Lapolla et al., 1984). The full-length cDNA for the mouse ~ subunit was 
previously isolated in our own laboratory (Gu et al., 1990). Each of the 
cDNAs was subcloned into the multiple cloning sites of a SV-4ff-based ex- 
pression vector, pSM (Brodsky et al., 1990). 
mAb210 (Guillick  and Lindstrom, 1983;  Ratnam et al.,  1986),  a  rat 
monoclonal antibody directed against the NH2-terrninus of ct subunit, and 
mAb124 (Tzartos et al., 1981), a rat monoclonal antibody recognizing the 
13 subunit, were generous gifts of Dr. Jon Lindstrom (University of Penn- 
sylvania, Philadelphia, PA). Mouse monoclonal antibody mAb88B (Froeh- 
ner et al., 1983), which recognizes the cytoplasmic loop of the ~ subunit, 
was kindly provided by Dr. Stanley Froehner (University of North Caro- 
lina, Chapel Hill, NC). 
cDNA Constructs of  A ChR a Subunit 
Intact, truncated, and chimeric proteins were derived from full-length cDNAs 
coding for the ot subunit of the mouse muscle nicotinic AChR. The con- 
structs a211  and ctM1 were made by amplification of the corresponding 
sequences of the full-length ot subunit cDNA with PCR. We engineered 
a211-CD8 and a211-VSVG by fusing the transmembrane and cytoplasmic 
domains of the human T-lymphocyte CD8 (Littman et al., 1985) and the 
vesicular stomatitis virus (VSV) G protein (Rose and Iverson, 1979) to the 
carboxyl side of amino acid residue 211 of the AChR a  subunit, respec- 
tively (see Fig. 1). The ce211-GPI was made by fusing the glycosylphos- 
phatidylinositol (GPI) anchor signals from human placental alkaline phos- 
phatase (HPAP) downstream of residue 211 of the et subunit (Lin et al., 
1990).  Each of the cDNA constructs was cloned into expression vector 
pSM and its sequence confirmed by dideoxynucleotide DNA sequencing 
(Sequenase kit; United States Biochem Corp., Cleveland, OH). Amino 
acids were numbered according to their position in the mature protein 
(signal peptide cleaved) sequence of c~ subunit. 
Transfection of COS Cells 
An  adenovirus-mediated,  DEAE-dextran  transfection  procedure  was 
adopted to introduce expression vectors into COS cells (Forsayeth and 
Garcia, 1994). For a 10-cm dish of cells, 5.0 ml of Dulbecco's modified Ea- 
gle's medium (DMEM H-21), 1.0 ml of Adgpt lysate (an E1 defective ade- 
novirus), 0.24 mg of DEAE-dextran, and an appropriate amount of plas- 
mid  DNA  were  mixed  and  added  to  cultured  COS  cells  at  ~60% 
confluence. For Western blot, immunoprecipitation, and pulse-chase la- 
beling experiments in which only one or two subunits were expressed, 4 
ttg of each plasmid was used. For analysis of cell surface AChR expres- 
sion, cDNAs for c~, B, ~, and ~ subunits were 2.64, 1.32, 0.52, and i  p,g, re- 
spectively, per 10-cm dish (Gu et al., 1991). After incubation in a CO2 in- 
cubator at 37°C for 2 h, the transfection mixture was removed, and the 
cells were rinsed with PBS before being returned to the incubator in 10 ml 
of growth medium (10% FBS in DMEM H-21 supplemented with 2 mM 
glutamine, 100 U/ml of penicillin, and 100 U/ml of streptomycin). 
Metabolic Labeling 
COS cells were labeled metabolically 48 h after transfection. Briefly, after 
a 30-rain preincubation at 37°C in cysteine- and methionine-free DMEM 
H-21, COS cells were labeled for 30 min at 37°C with 200 p,  Ci/ml Tran35S  - 
label (1,159 Ci/mmol, ICN Biomedicals, Costa Mesa, CA) in cysteine- and 
methionine-free DMEM H-21. Cells were washed with DMEM H-21 sup- 
plemented with 2 mg/ml each of cysteine and methionine and then chased 
for 6 h with DMEM H-21 containing 10% FCS. At the end of the chase 
period, the media were collected, and the labeled cells scraped off the dish 
with ice-cold PBS, pelleted by centrifugation, and solubilized in an extrac- 
tion buffer containing 50 mM Tris-HCl, pH 7.4, 50 mM NaCI, 1% Triton 
X-100, 1 mM EDTA, 1 mM EGTA, 1 mM sodium tetrathionate, 1 mM 
N-ethylmaleimide, 1 mM benzamidine, 0.4 mM PMSF, 20 o,g/ml leupep- 
tin, 10 p~g/ml pepstatin, and 10 U of aprotinin (Chavez et al., 1992; Gu et 
al., 1991). Cell lysates were pelleted to remove insoluble materials. The 
chasing media and the cleared cell extracts were each divided into two 
equal parts. Individual aliquots were assayed for total a subunit protein by 
immunoprecipitation with mAb210 and for folded tx subunit by precipita- 
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Figure 1.  Diagram  of the  intact,  truncated,  and  chimeric con- 
structs of AChR  subunit proteins. (A) Protein encoded by full- 
length mouse AChR  ct  subunit cDNA.  (B)  Truncated  proteins 
expressed by et211 and ctM1 cDNAs, and fusion proteins encoded 
by a  set of chimeric a  subunit cDNAs. The arrows indicate the 
last  amino  acids  encoded  by  AChR  tx  subunit.  Hydrophobic 
transmembrane  domains  of the chimeric constructs are  under- 
lined.  For fusion protein  a211-HPAP,  the arrowhead  indicates 
the site where peptide cleavage and addition of GPI anchor are 
predicted to occur within cells. Sequences are shown in one-letter 
amino acid notation. 
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formed for 2 h at 4°C with agitation. A rabbit anti-rat secondary antibody 
and protein G-Sepharose were used to precipitate the mAb210-contain- 
ing samples. The Sepharose pellets were washed three times with 50 mM 
Tris-HCl buffer, pH 7.4, containing 0.5 M NaC1 and 1% Triton X-100. The 
samples were heated for 5 min at 100°C in gel loading buffer containing 
5%  J3-mercaptoethanol and  electrophoresed through  12.5%  SDS-poly- 
acrylamide gels. The gels were dried, fluorographed, and exposed to film 
(BioMax; Kodak, Rochester, NY). The relative optical density of the pro- 
tein bands on the film was semiquantified using the software NIH Image 
(National Institutes of Health, Bethesda, MD) following scanning of the 
properly exposed films into a computer. Throughout this process, all sam- 
ples were handled identically. 
Surface Toxin Binding Assay 
24 h after transfection, COS cells were trypsinized and replated into 12- 
well tissue culture dishes. After an additional 24 h in culture, surface ex- 
pression of a-BuTx binding sites was determined by incubating intact cells 
in each well for 90 min at 37°C with 5 nM [125I]ct-BuTx (220 Ci/mmol; Am- 
ersham Corp., Arlington Heights, IL) in DMEM H-21. Unbound ct-BuTx 
was then removed by washing the cells with PBS. The amount of bound 
toxin  was  determined  by  measuring  the  radioactivity  with  a  gamma 
counter after solubilizing the cells in 0.1 N NaOH. 
Immunoprecipitation of Toxin-binding Sites with 
Subunit-specific Antibodies 
Immunoprecipitation of expressed proteins with subunit-specific antibod- 
ies was performed as described previously (Gu et al., 1989; Verrall and 
Hall, 1992). 48 h after the transfection, COS cells were scraped off the dish 
(10 cm), pelleted by centrifugation, and lysed in 0.4 ml of the Triton X-100 
extraction buffer. One tenth of the lysates (0.04 ml) were incubated with 4 
nM [t25I]ct-BuTx and 80 nM of each of the primary antibodies in a total 
volume of 0.5 ml for 1 h on ice. 2 Ixl of rabbit anti-rat (for mAb210 and 
mAb124) or rabbit anti-mouse (for mAb88b) secondary antisera (Cappel 
Research Products, Durham, NC) were then added to each sample. After 
an additional 1-h incubation on ice, 50 p~l of Standardized Pansorbin cells 
(10% suspension of fixed Staphylococcus aureus cells; Calbiochem-Nova- 
biochem Corp., La Jolla, CA) was added, and the samples were continu- 
ously mixed in a rotatory mixer for 30 min at 4°C. The Pansorbin cells 
were then washed with the extraction buffer containing 0.5 M NaC1 (with- 
out protease inhibitors), pelleted by centrifugation, and counted for radio- 
activity in a  gamma counter. Control immunoprecipitation experiments 
were carried out using sham transfected cells. 
Formation of a ligand-binding site by ~  heterodimers was determined 
by measuring the inhibition of [125I]c~-BuTx binding by d-tubocurarine 
(dTC) (Blount and Merlie, 1989).  Immunoprecipitation described above 
was  carried  out  with  the  following modifications:  Primary  antibodies 
(mAb88B) were first incubated with cell extracts for 1 h on ice. Secondary 
antibodies and dTC were added to the samples and incubated for 30 min. 
Finally, [125I]c~-BuTx (1 nM) was added and incubation was continued for 
30  min.  [1251]c~-BuTx bound to  heterodimer was precipitated using the 
Standardized Pansorbin cells. 
Velocity Sedimentation  on Sucrose Gradient 
48 h  after the transfection, COS cells grown in a  10-cm dish were incu- 
bated on ice with 10 nM [125I]a-BuTx in 10 mM phosphate, pH 7.4, 10 mM 
EDTA, 0.5% BSA, and 0.1% saponin for 2 h (Blount et al., 1990; Verrall 
and Hall,  1992). The labeled cells were then washed three times in the 
same buffer without [1251]ct-BuTx, scraped off the plate with a rubber po- 
liceman, pelleted by brief centrifugation, and lysed in 0.4  ml extraction 
buffer. Cell lysates (0.04  ml) were loaded onto a 5-20%  continuous su- 
crose gradient. Bovine alkaline phosphatase (6.3 S) and bovine hemoglo- 
bin (4.3  S) were included in the cell lysates as markers. Gradients were 
centrifuged at 65,000 rpm in a rotor (model VTi65; Beckman Instrs., Ful- 
lerton, CA) at 4°C for 80 min and fractionated into 105 ~1 aliquots (Saedi 
et al., 1991,  Verrall and  Hall,  1992).  Fractions were then counted in a 
gamma counter. 
Figure 2.  Expression, folding, and assembly of the truncated NH2-terminal fragments and the full-length a  subunit. (A) Fluorography 
showing the expression, folding, and assembly of tx211,  txM1, and the full-length cx subunit. COS cells transfected with each of the cDNAs 
encoding ct211, aM1, or the full-length o~ subunit in combination with ~ were labeled overnight with [35S]methionine. Cell lysates were 
divided into three equal parts. Total, correctly folded, and assembled ~x subunits were isolated by immunoprecipitation with antibody 
mAb210, by precipitation with et-BuTx-Sepharose, and by immunoprecipitation with antibody mAb88B, respectively. The precipitates 
were analyzed by 12.5% reducing SDS-acrylamide gels and fluorography. The lower bands in lane 1, 2, and 3 correspond to the nongly- 
cosylated peptide. The positions of molecular mass markers (expressed in kD) are indicated on the left. (B) a211 failed to form a high 
affinity ligand-binding site when coexpressed with the full-length ~ subunit. Formation of a ligand-binding site was determined by mea- 
suring dTC inhibition of a-BuTx binding. Triton X-100 lysates of the transfected COS cells were incubated for 90 min with [125I]et-BuTx 
(1 nM) in the presence of dTC. Toxin bound to heterodimers was immunoprecipitated using mAb88b. Nonspecific binding was deter- 
mined by addition of excess unlabeled ~t-bungarotoxin (1 wM). Control specific binding was defined by addition of no ligand other than 
[125I]et-BuTx (total minus nonspecific binding). 
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Immunofluorescence  staining was performed as described  before (Ral- 
ston and Hall, 1989). Briefly, transfected  COS cells cultured  in chamber 
slides were fixed for 10 rain in 2% paraformaldehyde  in PBS, pH 7.4, and 
rinsed in cold PBS. After a preincubation  in PBS containing 10% bovine 
serum  and 0.05% saponin  at 4°C for 20 min to permeabilize  the mem- 
brane, cells were incubated at 4°C for 1 h with rhodamine-conjugated 
et-BuTx (for staining of tt211 and ct211-GPl), mAb88B  (for 6 subunit), 
and a polyclonal  antibody  to ER membrane proteins (for ER marker; 
Louvard et al., 1982). After a brief rinse in cold PBS, cells were incubated 
with rhodamine-conjugated  goat anti-mouse (for 8 subunit) or FITC-con- 
jugated sheep anti-rabbit (for  ER marker)  secondary  antibodies.  The 
slides  were  examined  under  a  fluorescence  microscope  (Nikon  Inc., 
Melville, NY) equipped with the appropriate filters. 
Western Immunoblotting 
Lysates of the transfected COS cells were denatured by heating at 95°C 
for 5 min in SDS gel-loading buffer containing 13-mecaptoethanol,  electro- 
phoresed on a 12.5% SDS-polyacrylamide  gel (Laemmli, 1970), and then 
transferred to nitrocellulose membranes. After preincubation in PBS/0.3% 
Tween  20 containing  3%  BSA to block nonspecific binding, the mem- 
branes were  incubated  with  primary  antibodies  in  the same  blocking 
buffer and washed with PBS/Tween 20. Antibodies bound to the membrane 
were  detected with  horseradish  peroxidase-conjugated  secondary  anti- 
bodies and enhanced chemoluminescent reagents (ECL; Amersham Corp.). 
Results 
The NH2-terminal Domain of the ~ Subunit Folds but 
Does Not Associate with the 8 Subunit 
Before the ~  subunit can be assembled into the pentam- 
eric receptor, it must undergo a folding reaction in which it 
acquires the ability to bind et-BuTx (Merlie and Sebbane, 
1981; Merlie and Lindstrom, 1983). To determine if a sig- 
nal peptide-cleaved fragment of the AChR e~ subunit trun- 
cated at the NH2-terminal boundary of the first transmem- 
brane domain (et211; Fig.  1)  can fold and associate with 
the ~ subunit, we expressed the fragment in COS cells that 
were metabolically labeled with [35S]methionine. Radioac- 
tive et peptide was precipitated from a cell lysate, either by 
an antibody to the NHz-terminal domain (mAb 210, Guillick 
and Lindstrom, 1983; Ratnam et al.,  1986) or by et-BuTx- 
Sepharose. Thus, the a211  peptide, like the full-length c~ 
subunit  or  a  truncated  c~  fragment  containing  the  first 
transmembrane domain (ctM1), can fold to the toxin-bind- 
ing conformation (Fig. 2 A; Wang et al., 1996). When c~211 
is coexpressed in metabolically labeled COS cells with the 
8 subunit, however, no association between the two sub- 
units  was  detected as measured by immunoprecipitation 
with an antibody to the 8 subunit, mAb88B (Froehner et 
al., 1983). In contrast, both c~M1 and the full-length et sub- 
unit  were  coimmunoprecipitated by the  8  subunit  anti- 
body, indicating that in each case a  complex with the 
subunit had been formed (Fig. 2 A). Sucrose gradient sedi- 
mentation experiments also failed to demonstrate associa- 
tion  between  folded a211  and  the  6  subunit  (data  not 
shown). As a final test, the antagonistic cholinergic ligand, 
dTC,  failed  to  inhibit  toxin  binding  in  lysates  of cells 
cotransfected with cDNAs for ct211 and the ~ subunit. In 
contrast, the association of both ctM1 and the a with 8 sub- 
unit results in the formation of a high affinity ligand bind- 
ing site (Fig. 2 B; Blount and Merlie,  1989;  Verrall  and 
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Figure  3.  The  ct  NH2-termi- 
nal fragments fused to  non- 
specific  transmembrane  do- 
mains  assemble  with  6  to 
form  a  heterodimer  with  a 
high  affinity  ligand-binding 
site. (A) COS cells grown in a 
10-cm dish were transfected 
with each of the chimeric et 
subunit cDNAs alone (cross- 
hatched bars) or with the full- 
length ~ subunit (black bars). 
One tenth of the cell extracts 
from  each  dish  were  incu- 
bated  with  [125I]ct-BuTx  (10 
nM),  and  assembled  het- 
erodimers were immunopre- 
cipitated using mAb88b. (B) 
Sucrose gradient sedimenta- 
tion was performed to iden- 
tify heterodimers formed by 
chimeric oL constructs and the 
subunit. COS cells grown in 
a  10-cm  dish  were  trans- 
fected with cDNAs encoding, 
in  the  upper  panel,  ct211- 
CD8 (open  circles)  or ot211- 
CD8 plus 8 (filled circles); in 
the lower panel, u211-VSVG (open squares)  or ct211-VSVG plus 8 (solid squares).  Cells were permeabilized with 0.1% saponin and in- 
cubated with 10 nM of [lZSI]et-bungarotoxin for 90 min at 4°C, and washed with PBS, One tenth of Triton X-100 extracts in a culture dish 
were applied to a 5-20% sucrose gradient as described. (C) Chimeric a  NH2-terminal domains form a high affinity ligand-binding site 
with the ~ subunit. COS cells were transfected with cDNAs encoding aM1 plus 6 (asterisks),  a211-CD8 plus ~ (filled circles), and et211- 
VSVG plus ~ (solid squares).  Cell lysates were processed for analysis of dTC inhibition of [125I]et-BuTx binding as described in Fig. 2 B. 
The Journal of Cell Biology, Volume 135, 1996  812 Hall,  1992).  Thus,  the  soluble,  folded  NH2-terminal  do- 
main of the a  subunit  does not assemble with the ~ sub- 
unit. 
Nonspecific Peptide Sequences Can Replace M1 to 
Support Heterodimer Assembly 
One explanation for the inability of a211 to associate with 
the ~ subunit is that information required for subunit asso- 
ciation is contained within the M1 region. To test this pos- 
sibility, constructs were made encoding chimeric proteins 
in which at211 was fused to the transmembrane region of 
either the VSV glycoprotein (VSV G  protein) or the lym- 
phocyte  surface  antigen  CD8  (Rose  and  Iverson,  1979; 
Littman et al., 1985; Fig. 1 B). Each of these chimeric pro- 
teins was then expressed in COS cells along with the 5 sub- 
unit. In each case the fusion protein folded to a toxin-bind- 
ing form that associated with the 5 subunit  as shown by 
immunoprecipitation experiments (Fig. 3 A). Sucrose gra- 
dient experiments in both cases showed a major peak at 
approximately 5.3  S,  indicating  the  formation  of a  het- 
erodimer (Fig.  3  B).  Moreover, the  heterodimers bound 
dTC with a high affinity, as shown by inhibition of toxin 
binding (Fig. 3 C) that was indistinguishable from that of 
the uml~ heterodimer (Fig. 2 D). We conclude from these 
experiments that the M1 region of the et subunit is not spe- 
cifically  required  for heterodimer  formation with  the 
subunit and that transmembrane domains from other pro- 
teins are equally effective. 
Retention of a211 in the ER Does Not Result in 
Association with the 8 Subunit 
Assay of [125I]a-BuTx binding  activity on the  surface of 
transfected COS cells showed that each of the fusion pro- 
teins, like ctM1,  is almost completely retained intracellu- 
larly (Fig. 4, A and B). In contrast, a substantial amount of 
et211,  which  lacks  a  transmembrane domain,  is  secreted 
into the medium (Fig. 4 B; Wang et al., 1996). A  possible 
role of the attached transmembrane region may thus be to 
retain ct211 in the endoplasmic reticulum, allowing associ- 
ation  to occur.  We  tested  this  idea  by treating  cells  ex- 
pressing the et211 peptide and the ~ subunit with brefeldin 
A, which prevents transport of secretory and membrane- 
bound  proteins  from  the  ER  to  the  Golgi  apparatus 
(Klausner et al., 1992). Even after brefeldin A  treatment, 
however,  no  evidence  was  found  for  the  association  of 
at211 with the 8 subunit (Fig. 5 A). To verify that ct211 was 
retained after treatment with brefeldin A  and that it was 
present in the same cellular compartment as the g subunit, 
transfected cells treated with brefeldin A  were examined 
by  immunofluorescence.  The  distribution  of  the  a211 
polypeptide in brefeldin A-treated cells was exactly the 
same as that of an authentic ER marker (Ralston and Hall, 
1989); moreover, the 5 subunit was also demonstrated to 
be in the ER (Fig. 5 B). We conclude that both a211 and 8 
are in the ER but that at211 is unable to associate with the 
subunit because it is not tethered to the membrane. 
Membrane Tethering via Glycolipid, Coupled with ER 
Retention, Enables a211 to Assemble 
To see  if the  NH2-terminal  domain  can  be  attached  in 
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Figure 4.  ct-BuTx binding activity of the truncated and chimeric 
c~ subunit proteins on the cell surface and in the culture medium. 
(A)  [125I]ct-BuTx binding  sites  expressed on the  plasma mem- 
brane of the transfected COS cells (dark bars), and total toxin 
binding in cell lysates immunoprecipitated with mAb210 (cross- 
hatched bars). The data represent [125I]a-BuTx bound per well 
(2.5-cm diam) of transfected cells. (B) Secretion of the expressed 
ct subunit proteins was detected by measuring [125I]o~-BuTx  bind- 
ing activity  in the culture  media of COS  cells transfected with 
each of the cDNAs as indicated.  1 ml of the culture  media from 
each well of the transfected cells was used for immunoprecipita- 
tion assay with mAb210, and the results were expressed as [125I]ct- 
BuTx bound. 
other ways that would allow it to associate with the ~ sub- 
unit, we expressed a211  as a fusion protein attached to a 
segment (the COOH-terminal 29 amino acids) of HPAP 
that serves as a  signal sequence  for the attachment of a 
GPI residue, linking the polypeptide to the cell membrane 
(Fig. 1 B; Lin et al., 1990).  Cells transfected with cDNA for 
the fusion protein expressed toxin-binding activity on their 
surface in a form that could be released into the medium 
by treatment with phosphatidylinositol-specific phospholi- 
pase C (PI-PLC; Fig. 6 A, lane 5), indicating that a GPI an- 
chor  had  been formed  (Lin  et  al.,  1990;  Kemble et  al., 
1994).  When coexpressed  with  the  ~  subunit,  however, 
a211-GPI did not associate with the ~ subunit, either on 
the  cell  surface  or  in  the  ER.  Thus,  the  truncated  e~ 
Wang et al. Membrane Tethering in AChR Subunit Assembly  813 Figure 5.  Brefeldin A  fails to facilitate a211 assembly with the ~ subunit, though it retains the peptide in the ER. (A) COS cells trans- 
fected with a211 plus g cDNAs were incubated in control growth medium (open circles) or in growth medium containing brefeldin A  (5 
~g/ml, filled circles)  at 37°C for 6 h. They were then lysed with extraction buffer containing Triton X-100. Inhibition of [125I]a-BuTx 
binding by dTC was determined as described in Fig. 2 B. (B) Brefeldin A  causes the retention of a211 in the ER. Cells transfected with 
cDNAs encoding a211 and 8 were treated with brefeldin A as in A. Immunofluorescence staining was done using rhodamine-conjugated 
ot-BuTx (for a211), mAb88B (for g), and a polyclonal antibody to ER membrane (for ER marker). In the brefeldin A-treated group, 
the bottom row stained with anti-ER antibody shows the same cells as the top row. 
Figure 6.  When retained in the ER, the GPI-tethered o~211 assembles with the g subunit to form a high affinity ligand-binding site. (A) 
An immunoblot with mAb210 shows specific association of the ~x211-GPI with g after brefeldin A treatment. Cells coexpressing c~211-GPI 
and the g subunit were extracted with 13-D-octylglucoside. Immunoblotting was performed using crude cell lysates (lanes I  and 2) or us- 
ing mAb88b immunoprecipitates of the crude cell lysates (lanes 3 and 4). In lanes 2 and 4, cells were treated with brefeldin A  (5 txg/ml) 
at 37°C for 6 h. Lane 5 shows the surface GPI-anchored c~211 released into culture medium following cleavage by PI-PLC. (B) Forma- 
tion of a  high affinity ligand-binding site.  COS cells transfected  with a211-HPAP  plus g were incubated  in control growth medium 
(squares) or in growth medium containing brefeldin A  (5 I~g/ml; filled circles)  at 37°C for 6  h. They were then lysed with extraction 
buffer containing 60 mM [3-o-octylglucoside. Inhibition of [125I]a-BuTx  binding by dTC was determined as described in Fig. 2 B. 
The Journal of Cell Biology, Volume 135, 1996  814 polypeptide  could not be  coimmunoprecipitated  with  an 
anti--~ antibody (Fig. 6 A), and inhibition of toxin binding 
by dTC was not observed (Fig. 6 B). 
A  possible  explanation  for the  failure  of folded oL211- 
GPI to form a  heterodimer is that its effective concentra- 
tion  in  the  ER is  too low for assembly.  A  large  portion 
(80-90%)  of a211-GPI  is  expressed  on  the  cell  surface 
(Fig. 7) to which it is rapidly transported within 10 min of 
synthesis  (data  not shown).  To test  this  idea, we treated 
cells expressing c~211-GPI and the ~ subunit with brefeldin 
A.  In the presence of the drug, folding of a211-GPI was 
not affected (Fig. 7 A), and the peptide was completely re- 
tained  in the  ER  (Fig.  7).  Moreover,  the c~211-GPI that 
was retained  in  the  ER  associated  with  the  8  subunit  as 
shown by coimmunoprecipitation with 8-specific antibody 
mAb88B  (Fig.  6 A, lane  4).  In contrast,  when a211-GPI 
was  coexpressed  with  the  13  subunit  in  the  presence  of 
brefeldin A, a  monoclonal antibody (mAb124; Tzartos et 
al.,  1981) recognizing the  13 subunit  precipitated  no toxin 
binding  activity  (data  not  shown).  Thus,  the  interaction 
between the a211-GPI and the ~ subunit is specific, as the 
fragment does not associate with the 13 subunit. The associ- 
ation between a211-GPI and the 8 subunit resulted  in the 
formation of a high-affinity binding site for dTC that is in- 
distinguishable from that of the full-length aS heterodimer 
(Fig.  6  B). We conclude that  a211  contains  all  of the se- 
quence information necessary for folding, for specific sub- 
unit  association,  and  for  formation  of  a  high-affinity 
ligand-binding  site.  Efficient  interaction  with  the  ~  sub- 
unit,  however,  requires  that  a211  be  retained  in the  ER 
and be tethered to the membrane. 
Discussion 
Previous experiments on AChR assembly in our own and 
other laboratories  have  implicated  the luminal,  NH2-ter- 
minal domain as the part of the AChR subunits that is re- 
sponsible  for their  specific association  into heterodimers 
with ligand-binding sites (Yu and Hall, 1991, 1994; Verrall 
and  Hall,  1992;  Sumikawa  and  Nishizaki,  1994;  Kreien- 
kamp et al.,  1995). Here we show that although the NH2- 
terminal  domain of the ct subunit expressed in COS cells 
can fold autonomously into a  conformation that allows it 
to bind  ot-BuTx, it does not associate  with  the  8  subunit 
unless two conditions  are met: It must be retained  in the 
ER, and it must be attached to the membrane. 
Like  the  subunits  of other  oligomeric membrane  pro- 
teins (Hurtley and Helenius,  1989; Doms et al., 1993), un- 
associated  subunits  and  assembly  intermediates  of  the 
AChR are normally retained  in the ER. When expressed 
alone, none or only trace amounts of the AChR subunits 
are seen on the surface (Smith et al., 1987; Gu et al., 1989; 
Figure 7.  (A) Brefeldin A blocked the surface transport of a211-GPI and AChR pentamer (az138e), but had little  effect on c~ subunit 
folding.  COS cells grown in a 6-cm dish were transfected with cDNAs for a211-GPI, or for the a, 13, ~ and ~ subunits, and replated to a 
12-well culture dish. Intact cells in each well (2.5-cm diam) were preincubated with unlabeled e~-BuTx (1 IxM, 37°C for I h) to block pre- 
existing surface receptor. After washing with PBS to remove unbound toxins, cells were incubated with control medium or medium con- 
taining brefeldin A (5 i~g/ml) for 6 h, and processed for surface [125I]a-BuTx binding.  An equal number of cells in separate wells were 
treated in the same manner and lysed with detergent. Total a-BuTx binding activity in the lysates was determined by immunoprecipita- 
tion with mAb210. (B) Retention of the GPI-tethered a211 in the ER by brefeldin A. Cells transfected with cDNAs as indicated were 
treated with brefeldin A as in A. Immunofluorescence staining was done using rhodamine-conjugated u-BuTx (for c~211-GPI), mAb88B 
(for ~), and a polyelonal antibody to ER membrane (for ER marker). The brefeldin A-treated cells were double labeled with antibodies 
against the indicated subunits (top row) and with the ER marker antibody (bottom row). 
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sembly occurs in the ER, retention presumably promotes 
efficient interaction  of the subunits  with each other  and 
possibly with assembly cofactors in the ER. In our experi- 
ments, c,  M1  and each of the chimeric proteins a211-CD8 
and a211-VSVG were retained in the ER, where they effi- 
ciently formed heterodimers with  the  ~ subunit.  In con- 
trast, a211, which  lacks a  transmembrane domain and is 
secreted into the medium, and a211-GPI, which is rapidly 
transported to the surface, do not associate with the g sub- 
unit. These results suggest that the signal for retention of 
the a  subunit resides in its transmembrane domains. The 
interactions that are responsible for retention are likely to 
be complex. Thus, the transmembrane domain of CD8 in 
its normal context does not result in ER retention  (Litt- 
man et al., 1985; Ralston and Halt, 1989), but does so when 
attached to a211. Studies of the a chain of the T cell recep- 
tor have identified a 23-amino acid sequence in the trans- 
membrane domain that is both necessary and sufficient for 
retention in the ER (Bonifacino et al., 1990). 
The importance of retention in the ER for heterodimer 
formation is  seen most clearly for a211-GPI.  When  ex- 
pressed  under  normal  conditions,  a211-GPI  was  trans- 
ported to the cell surface within 10 min, and no association 
with the g subunit was observed. After brefeldin A  treat- 
ment, however, which prevents transport of proteins out 
of the ER, a211-GPI readily associated with the ~ subunit 
to form a heterodimer with a ligand-binding site. Since the 
subunit is confined to the ER, the steady-state concen- 
tration of a211-GPI in the ER under normal conditions is 
presumably too low for efficient heterodimer formation to 
occur. To see if heterodimer formation could occur if both 
subunits were on the surface, we made a GPI construct of 
the g NH2-terminal domain (8224-GPI) and coexpressed it 
with ~211-GPI. Although g224-GPI was transported to the 
surface along with cc211-GPI, no heterodimer  formation 
was detected  (Wang,  Z.-Z., and Z.W.  Hall, unpublished 
experiments). We were also unable to obtain heterodimer 
formation, however, when c~211-GPI and g224-GPI were 
coexpressed in the presence of brefeldin A. Thus, we can- 
not rule out the possibility that g224-GPI is not folded cor- 
rectly. 
The  NH2-terminal  domain  of the  ~x subunit  must  not 
only be present in the ER for assembly to occur, it must 
also be attached to the membrane. Since et211 can be effec- 
tively anchored to the membrane by each of several trans- 
membrane sequences or by a glycolipid link, the informa- 
tion for specific subunit  interaction  and for formation of 
the ligand-binding site must arise solely from the NH2-ter- 
minal domain. Attachment to the membrane appears to be 
necessary to facilitate the assembly process. This may be a 
general feature of membrane protein assembly as homo- 
oligomeric viral membrane proteins are known to assem- 
ble less efficiently when they are expressed as anchor-free 
fragments (Singh et al., 1990; Doms et al., 1993). 
Tethering a  folded  polypeptide to the membrane con- 
fines its diffusional movement to a  two-dimensional sur- 
face and orients it for interaction with other subunits. Such 
an effect could explain the effect that we observe. Alterna- 
tively, interaction with a  membrane-bound cofactor may 
be required for efficient subunit association. For assembly 
of the AChR, calnexin could be one such candidate; inter- 
action with other proteins may also be important. Calnexin, 
a membrane protein residing in the ER, has been shown to 
associate with the c~ subunit of the AChR and is thought to 
play a role in the folding and assembly of oligomeric pro- 
teins  (Gelman  et  al.,  1995).  Although  the  interaction  of 
calnexin with viral membrane proteins appears to require 
oligosaccharide trimming (Hammond and Helenius, 1995), 
inhibitors of the trimming reaction have no effect on het- 
erodimer  formation  in  an  in  vitro  translation  system 
(Shtrom and Hall, 1996). Further investigation will be re- 
quired to determine the importance of membrane-bound 
factors. The present experiments give impetus to a search 
for assembly cofactors by establishing that the NH2-termi- 
nal domain of the et subunit, in the absence of other parts 
of the protein, is competent to fold, to assemble with the 
subunit, and to form an authentic ligand-binding site, but 
only does so when tethered to the ER membrane. 
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